NCT07084402 - Short-term Bactericidal Effect of Contezolid in MAC-PD | Biotech Hunter

Enrollment

188

Participants

Timeline

Start Date

July 24, 2025

Primary Completion Date

July 24, 2027

Study Completion Date

December 31, 2027

Conditions

Mycobacterium Avium Complex Pulmonary Disease

Interventions

DRUG

Contezolid

contezolid 800mg po q12h for 6 months

DRUG

Azithromcyin

azithromycin 500mg po tiw (250mg po tiw if weight below 50kg) for 6 months.

DRUG

Rifampicin (RIF)

rifampicin 600mg po tiw for 6 months.

DRUG

Ethambutol

ethambutol 25mg/kg po tiw for 6 months.

Trial Locations (3)

ACTIVE_NOT_RECRUITING

Beijing Chest Hospital, Capital Medical University, Beijing

RECRUITING

China-Japan Friendship Hospital, Beijing

RECRUITING

Jiangxi Provincial Chest Hospital, Nanchang